Hedgehog signaling in cancer stem cells: a focus on hematological cancers
- PMID: 25691811
- PMCID: PMC4325629
- DOI: 10.2147/SCCAA.S58613
Hedgehog signaling in cancer stem cells: a focus on hematological cancers
Abstract
The stem cell paradigm was first demonstrated in hematopoietic stem cells. Whilst classically it was cytokines and chemokines which were believed to control stem cell fate, more recently it has become apparent that the stem cell niche and highly conserved embryonic pathways play a key role in governing stem cell behavior. One of these pathways, the hedgehog signaling pathway, found in all organisms, is vitally important in embryogenesis, performing the function of patterning through early stages of development, and in adulthood, through the control of somatic stem cell numbers. In addition to these roles in health however, it has been found to be deregulated in a number of solid and hematological malignancies, components of the hedgehog pathway being associated with a poor prognosis. Further, these components represent viable therapeutic targets, with inhibition from a drug development perspective being readily achieved, making the hedgehog pathway an attractive potential therapeutic target. However, although the concept of cancer stem cells is well established, how these cells arise and the factors which influence their behavior are not yet fully understood. The role of the hedgehog signaling pathway and its potential as a therapeutic target in hematological malignancies is the focus of this review.
Keywords: cancer stem cell; hedgehog signaling pathway; hematopoiesis; lymphoid; myeloid; stem cell.
Figures
Similar articles
-
New insight into hedgehog signaling in hematological malignancies.Leuk Lymphoma. 2015 Apr;56(4):858-65. doi: 10.3109/10428194.2014.938328. Epub 2014 Aug 18. Leuk Lymphoma. 2015. PMID: 24991722 Review.
-
Canonical and noncanonical Hedgehog/GLI signaling in hematological malignancies.Vitam Horm. 2012;88:25-54. doi: 10.1016/B978-0-12-394622-5.00002-X. Vitam Horm. 2012. PMID: 22391298 Review.
-
Targeting hedgehog in hematologic malignancy.Blood. 2012 Mar 8;119(10):2196-204. doi: 10.1182/blood-2011-10-383752. Epub 2012 Jan 5. Blood. 2012. PMID: 22223823 Review.
-
Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms.Am J Pathol. 2012 Jan;180(1):2-11. doi: 10.1016/j.ajpath.2011.09.009. Epub 2011 Nov 1. Am J Pathol. 2012. PMID: 22056910 Free PMC article. Review.
-
Understanding the Hedgehog Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Necessary Step toward a Cure.Biology (Basel). 2021 Mar 24;10(4):255. doi: 10.3390/biology10040255. Biology (Basel). 2021. PMID: 33804919 Free PMC article. Review.
Cited by
-
Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study.Cancer Chemother Pharmacol. 2019 Mar;83(3):463-472. doi: 10.1007/s00280-018-3748-8. Epub 2018 Dec 10. Cancer Chemother Pharmacol. 2019. PMID: 30536154 Free PMC article. Clinical Trial.
-
Ehrlichia SLiM ligand mimetic activates Hedgehog signaling to engage a BCL-2 anti-apoptotic cellular program.PLoS Pathog. 2022 May 16;18(5):e1010345. doi: 10.1371/journal.ppat.1010345. eCollection 2022 May. PLoS Pathog. 2022. PMID: 35576232 Free PMC article.
-
Re-Sensitizing Cancer Stem Cells to Conventional Chemotherapy Agents.Int J Mol Sci. 2023 Jan 20;24(3):2122. doi: 10.3390/ijms24032122. Int J Mol Sci. 2023. PMID: 36768445 Free PMC article. Review.
-
The Role of Mutated Calreticulin in the Pathogenesis of BCR-ABL1-Negative Myeloproliferative Neoplasms.Int J Mol Sci. 2024 Sep 12;25(18):9873. doi: 10.3390/ijms25189873. Int J Mol Sci. 2024. PMID: 39337361 Free PMC article.
-
Targeted Therapies for Pediatric AML: Gaps and Perspective.Front Pediatr. 2019 Nov 15;7:463. doi: 10.3389/fped.2019.00463. eCollection 2019. Front Pediatr. 2019. PMID: 31803695 Free PMC article. Review.
References
-
- Nguyen LV, Vanner R, Dirks P, Eaves CJ. Cancer stem cells: an evolving concept. Nat Rev Cancer. 2012;12(2):133–143. - PubMed
-
- Copley MR, Beer PA, Eaves CJ. Hematopoietic stem cell heterogeneity takes center stage. Cell Stem Cell. 2012;10(6):690–697. - PubMed
-
- Zon LI. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature. 2008;453(7193):306–313. - PubMed
-
- Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730–737. - PubMed
-
- Goardon N, Marchi E, Atzberger A, et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell. 2011;19(1):138–152. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources